Gerald E. Quirk - Oct 11, 2022 Form 3 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Signature
/s/ Todd Rosenthal, as attorney-in-fact
Stock symbol
SYRS
Transactions as of
Oct 11, 2022
Transactions value $
$0
Form type
3
Date filed
10/13/2022, 04:15 PM
Next filing
Sep 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SYRS Common Stock 8.7K Oct 11, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SYRS Stock Option (right to buy) Oct 11, 2022 Common Stock 14K $133.00 Direct F1
holding SYRS Stock Option (right to buy) Oct 11, 2022 Common Stock 4K $109.00 Direct F1
holding SYRS Stock Option (right to buy) Oct 11, 2022 Common Stock 7.5K $100.90 Direct F1
holding SYRS Stock Option (right to buy) Oct 11, 2022 Common Stock 6.72K $67.10 Direct F1
holding SYRS Stock Option (right to buy) Oct 11, 2022 Common Stock 6.07K $75.40 Direct F1
holding SYRS Stock Option (right to buy) Oct 11, 2022 Common Stock 3.72K $114.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested.

Remarks:

Exhibit 24 - Power of Attorney